Veru (VERU)
Develops oral candidates for obesity-related body composition and atherosclerotic inflammation.
$2.75
Pre-market+0.01 (+0.38%)
At close$2.74(+1.86%)
Something off on this page? Send us feedback.
Next report
Nov 26, 2026
in 84 days
EPS estimate
−$0.33
Revenue estimate
—
Fiscal quarter
Q4 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Dec '25Feb '26May '26Aug '26Nov '26
Reported−$0.07−$0.05−$0.50−$0.60−$0.26−$0.13−$0.30Pending
Estimate−$0.08−$0.06−$0.55−$0.37−$0.47−$0.31−$0.32−$0.33
Surprise+12.5%+16.7%+9.1%−64.4%+44.7%+58.1%+6.3%—
RevenueReportedEstimate
Feb '25May '25Aug '25Dec '25Feb '26May '26Aug '26Nov '26
Reported———$247.1K———Pending
Estimate$3.0M$725.0K——$2.1M$1.9M$1.7M—
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.33 | — | — |
| Aug 2026 | −$0.32 | −$0.30 | +6.3% |
| May 2026 | −$0.31 | −$0.13 | +58.1% |
| Feb 2026 | −$0.47 | −$0.26 | +44.7% |
| Dec 2025 | −$0.37 | −$0.60 | −64.4% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Dec 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Apr 2024 | |||
| Feb 2024 | |||
| Dec 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Dec 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Dec 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Dec 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Dec 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Dec 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Jan 2018 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Dec 2016 | |||
| Jul 2016 | |||
| Apr 2016 | |||
| Feb 2016 | |||
| Dec 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 26, 2026 | −$0.33 | — | — | — | — | — | — |
| Aug 10, 2026 | −$0.32 | −$0.30 | +6.3% | $1.7M | — | — | +18.9% |
| May 13, 2026 | −$0.31 | −$0.13 | +58.1% | $1.9M | — | — | −7.5% |
| Feb 11, 2026 | −$0.47 | −$0.26 | +44.7% | $2.1M | — | — | −2.6% |
| Dec 17, 2025 | −$0.37 | −$0.60 | −64.4% | — | $247.1K | — | +1.4% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||||||
| Aug 12, 2025 | |||||||
| May 8, 2025 | |||||||
| Feb 13, 2025 | |||||||
| Dec 16, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 8, 2024 | |||||||
| Apr 1, 2024 | |||||||
| Feb 8, 2024 | |||||||
| Dec 8, 2023 | |||||||
| Aug 10, 2023 | |||||||
| May 11, 2023 | |||||||
| Feb 9, 2023 | |||||||
| Dec 5, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 12, 2022 | |||||||
| Feb 9, 2022 | |||||||
| Dec 2, 2021 | |||||||
| Aug 12, 2021 | |||||||
| May 12, 2021 | |||||||
| Feb 10, 2021 | |||||||
| Dec 9, 2020 | |||||||
| Aug 13, 2020 | |||||||
| May 13, 2020 | |||||||
| Feb 12, 2020 | |||||||
| Dec 12, 2019 | |||||||
| Aug 8, 2019 | |||||||
| May 15, 2019 | |||||||
| Feb 13, 2019 | |||||||
| Dec 13, 2018 | |||||||
| Aug 14, 2018 | |||||||
| May 9, 2018 | |||||||
| Feb 14, 2018 | |||||||
| Jan 2, 2018 | |||||||
| Aug 8, 2017 | |||||||
| May 9, 2017 | |||||||
| Feb 9, 2017 | |||||||
| Dec 12, 2016 | |||||||
| Jul 28, 2016 | |||||||
| Apr 28, 2016 | |||||||
| Feb 2, 2016 | |||||||
| Dec 1, 2015 | |||||||